Clinical Trials Directory

Trials / Unknown

UnknownNCT01319214

Reducing Drug Craving Memories

Reconsolidation as a Treatment Target for Cocaine Addiction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to investigate the potential ability of Inderal (propranolol hydrochloride) to diminish the reconsolidation of motivationally potent drug-related cues in cocaine dependent participants. If effective in this laboratory model, Inderal may have clinical efficacy.

Conditions

Interventions

TypeNameDescription
DRUGInderalInderal vs. placebo will be administered with or without cocaine cues

Timeline

Start date
2011-03-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2011-03-21
Last updated
2011-05-19

Source: ClinicalTrials.gov record NCT01319214. Inclusion in this directory is not an endorsement.

Reducing Drug Craving Memories (NCT01319214) · Clinical Trials Directory